Related Experiment Video
Updated: Nov 19, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Does a history of cardiovascular disease or cancer affect mortality after SARS-CoV-2 infection?
Insights
Age, male sex, and distant metastatic cancer were key risk factors for COVID-19 mortality in Norway. Other cardiovascular diseases and non-metastatic cancer did not significantly increase death risk after SARS-CoV-2 infection.
Area of Science:
- Epidemiology
- Public Health
- Infectious Diseases
Background:
- Cardiovascular disease and cancer are potential risk factors for COVID-19 mortality.
- Previous studies suggested a link, necessitating further investigation.
Purpose of the Study:
- To determine if a history of cardiovascular disease or cancer impacts mortality risk following a COVID-19 diagnosis in Norway.
Main Methods:
- Data sourced from Norwegian national health registries.
- Regression models (univariable and multivariable) used to assess relative and absolute risks.
Main Results:
- Age, male sex, prior stroke, and distant metastatic cancer independently increased COVID-19 death risk.
- Myocardial infarction, atrial fibrillation, heart failure, hypertension, and non-metastatic cancer were not significant risk factors after adjusting for age and sex.
Conclusions:
- Age is the primary risk factor for COVID-19 death.
- Male sex, stroke, and distant metastatic cancer are significant risk factors for mortality after SARS-CoV-2 infection.
Background:
Cardiovascular disease and cancer have been described as possible risk factors for COVID-19 mortality. The purpose of this study was to investigate whether a history of cardiovascular disease or cancer affects the risk of dying after a COVID-19 diagnosis in Norway.
Material And Method:
Data were compiled from the Norwegian Surveillance System for Communicable Diseases, the Norwegian Cardiovascular Disease Registry and the Cancer Registry of Norway. Univariable and multivariable regression models were used to calculate both relative and absolute risk.
Results:
In the first half of 2020, 8 809 people tested positive for SARS-CoV-2 and 260 COVID-19-associated deaths were registered. Increasing age, male sex (relative risk (RR): 1.5; confidence interval (CI): 1.2-2.0), prior stroke (RR: 1.5; CI: 1.0-2.1) and cancer with distant metastasis at the time of diagnosis (RR: 3.0; CI: 1.1-8.2) were independent risk factors for death after a diagnosis of COVID-19. After adjusting for age and sex, myocardial infarction, atrial fibrillation, heart failure, hypertension, and non-metastatic cancer were no longer statistically significant risk factors for death.
Interpretation:
The leading risk factor for death among individuals who tested positive for SARS-CoV-2 was age. Male sex, and a previous diagnosis of stroke or cancer with distant metastasis were also associated with an increased risk of death after a COVID-19 diagnosis.
Related Concept Videos
Cancer Survival Analysis
Comparing the Survival Analysis of Two or More Groups
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction
Assumptions of Survival Analysis
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

